Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The **mitochondrial dicarboxylate carrier (SLC25A10)** is an integral membrane transporter protein of the inner mitochondrial membrane encoded by the SLC25A10 gene[1][2][3]. It exchanges dicarboxylates such as malate, succinate, and malonate for phosphate, sulfate, and thiosulfate using an antiport mechanism, playing a central role in metabolite shuttling for the Krebs cycle, gluconeogenesis, urea synthesis, fatty acid metabolism, and sulfur metabolism[1][2][3]. SLC25A10 modulates lipid homeostasis in adipocytes and liver, influences insulin sensitivity, maintains cellular redox and energy homeostasis, and interacts with pathways critical in cancer and metabolic diseases[1][3]. Loss-of-function mutations can result in severe mitochondrial disease and neurodegenerative disorders, and the transporter is considered a therapeutic target in metabolic syndrome, cancer, and diabetes[1][2][3].
Competitive inhibition of dicarboxylate transport (by analogues); Inhibition increases sensitivity to oxidative stress and traditional anticancer drugs in tumors
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Mitochondrial dicarboxylate carrier (SLC25A10).